Showing results (961-970 of 1,273) with videos related to

Sort By:
Pageof 128
Cancer Research|October 23, 1997
Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitroG Ferrandina, B Melichar, A Loercher, et al.
Leukemia & Lymphoma|May 15, 2015
Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemiaJennifer R Brown, Bethany Tesar, Lijian Yu, et al.
American Journal of Epidemiology|July 2, 2003
Structure of dietary measurement error: results of the OPEN biomarker studyVictor Kipnis, Amy F Subar, Douglas Midthune, et al.
Clinical Chemistry|April 27, 2004
Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham StudyDavid S Freedman, James D Otvos, Elias J Jeyarajah, et al.
Obesity (Silver Spring, Md.)|December 21, 2021
Interrelationships among age at adiposity rebound, BMI during childhood, and BMI after age 14 years in an electronic health record databaseDavid S Freedman, Amy J Goodwin-Davies, Lyudmyla Kompaniyets, et al.
The American Journal of Clinical Nutrition|January 14, 2022
An evaluation of the serum carbon isotope ratio as a candidate predictive biomarker of the dietary animal protein ratio (animal protein/total protein) in a 15-day controlled feeding study of US adultsDiane M O'Brien, Virag Sagi-Kiss, Susana A Palma-Duran, et al.
Blood|February 1, 1987
Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrowK C Anderson, J Ritz, T Takvorian, et al.
Leukemia|January 1, 1987
Expression of B cell activation antigens on normal and malignant B cellsA S Freedman, A W Boyd, A Berrebi, et al.
Kidney360|July 14, 2020
Profiling APOL1 Nephropathy Risk Variants in Genome-Edited Kidney Organoids with Single-Cell TranscriptomicsEsther Liu, Behram Radmanesh, Byungha H Chung, et al.
Contemporary Clinical Trials Communications|November 6, 2023
Physical Activity Together for Multiple Sclerosis (PAT-MS): A randomized controlled feasibility trial of a dyadic behaviour change interventionAfolasade Fakolade, Zain Awadia, Katherine Cardwell, et al.
Pageof 128